NO20001219D0 - Blanding for medikament-administrasjon - Google Patents

Blanding for medikament-administrasjon

Info

Publication number: NO20001219D0
Authority: NO; Norway
Prior art keywords: mixture; drug administration; administration; drug
Prior art date: 1997-09-09

Application number

NO20001219A

Other languages

English (en)

Other versions

NO20001219L (no

Inventor

Lisbeth Illum

Yu-Hui Cheng

Peter James Watts

Stanley Steward Davis

Original Assignee

West Pharm Serv Drug Res Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-09-09

Filing date

2000-03-09

Publication date

2000-03-09

2000-03-09 Application filed by West Pharm Serv Drug Res Ltd filed Critical West Pharm Serv Drug Res Ltd

2000-03-09 Publication of NO20001219L publication Critical patent/NO20001219L/no

2000-03-09 Publication of NO20001219D0 publication Critical patent/NO20001219D0/no

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
- A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics

Landscapes

Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Anesthesiology (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

NO20001219A 1997-09-09 2000-03-09 Blanding for medikament-administrasjon NO20001219D0 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9718986.4A GB9718986D0 (en)	1997-09-09	1997-09-09	Controlled release microsphere delivery system
PCT/GB1998/002692 WO1999012549A2 (en)	1997-09-09	1998-09-07	Controlled release microsphere delivery system

Publications (2)

Publication Number	Publication Date
NO20001219L NO20001219L (no)	2000-03-09
NO20001219D0 true NO20001219D0 (no)	2000-03-09

Family

ID=10818687

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20001219A NO20001219D0 (no)	1997-09-09	2000-03-09	Blanding for medikament-administrasjon

Country Status (10)

Country	Link
EP (1)	EP1011680A2 (no)
JP (1)	JP2001515862A (no)
AR (1)	AR017079A1 (no)
AU (1)	AU745511B2 (no)
CA (1)	CA2302762A1 (no)
GB (1)	GB9718986D0 (no)
NO (1)	NO20001219D0 (no)
NZ (1)	NZ502710A (no)
WO (1)	WO1999012549A2 (no)
ZA (1)	ZA987762B (no)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6194006B1 (en)	1998-12-30	2001-02-27	Alkermes Controlled Therapeutics Inc. Ii	Preparation of microparticles having a selected release profile
US6331317B1 (en)	1999-11-12	2001-12-18	Alkermes Controlled Therapeutics Ii Inc.	Apparatus and method for preparing microparticles
US6495166B1 (en)	1999-11-12	2002-12-17	Alkermes Controlled Therapeutics Inc.	Apparatus and method for preparing microparticles using in-line solvent extraction
US6705757B2 (en)	1999-11-12	2004-03-16	Alkermes Controlled Therapeutics, Inc. Ii	Method and apparatus for preparing microparticles using in-line solvent extraction
ES2169980B1 (es) *	1999-12-17	2003-11-01	Lipotec Sa	Microcapsulas para la liberacion prolongada de farmacos.
US6264987B1 (en)	2000-05-19	2001-07-24	Alkermes Controlled Therapeutics Inc. Ii	Method for preparing microparticles having a selected polymer molecular weight
US6495164B1 (en)	2000-05-25	2002-12-17	Alkermes Controlled Therapeutics, Inc. I	Preparation of injectable suspensions having improved injectability
US6824822B2 (en)	2001-08-31	2004-11-30	Alkermes Controlled Therapeutics Inc. Ii	Residual solvent extraction method and microparticles produced thereby
US6471995B1 (en)	2000-09-27	2002-10-29	Alkermes Controlled Therapeutics, Inc. Ii	Apparatus and method for preparing microparticles using liquid-liquid extraction
US20020114843A1 (en)	2000-12-27	2002-08-22	Ramstack J. Michael	Preparation of microparticles having improved flowability
CN1662260B (zh)	2002-06-25	2010-04-28	武田药品工业株式会社	缓释组合物的制备方法
WO2004039411A2 (en) *	2002-10-31	2004-05-13	Pfizer Products Inc.	Solid and semi-solid polymeric ionic conjugates
ZA200602347B (en)	2003-10-23	2007-09-26	Otsuka Pharma Co Ltd	Controlled release sterile injectable aripiprazole formulation and method
PL1734971T3 (pl)	2004-04-15	2012-08-31	Alkermes Pharma Ireland Ltd	Urządzenie o przedłużonym uwalnianiu na bazie polimeru
AU2005278894A1 (en)	2004-08-31	2006-03-09	Pfizer Products Inc.	Pharmaceutical dosage forms comprising a low-solubility drug and a polymer
US11246913B2 (en)	2005-02-03	2022-02-15	Intarcia Therapeutics, Inc.	Suspension formulation comprising an insulinotropic peptide
WO2008021133A2 (en)	2006-08-09	2008-02-21	Intarcia Therapeutics, Inc.	Osmotic delivery systems and piston assemblies
WO2008041245A2 (en) *	2006-10-05	2008-04-10	Panacea Biotec Ltd.	Injectable depot composition and it's process of preparation
NZ577281A (en)	2006-12-18	2011-12-22	Takeda Pharmaceutical	Sustained-release composition and method for producing the same
AU2008244523B2 (en)	2007-04-23	2012-02-16	Intarcia Therapeutics, Inc.	Suspension formulations of insulinotropic peptides and uses thereof
TWI410255B (zh)	2007-07-31	2013-10-01	Otsuka Pharma Co Ltd	阿立哌唑（Ａｒｉｐｉｐｒａｚｏｌｅ）懸浮液及冷凍乾燥調配物之製法
US8343140B2 (en)	2008-02-13	2013-01-01	Intarcia Therapeutics, Inc.	Devices, formulations, and methods for delivery of multiple beneficial agents
RU2547990C2 (ru)	2009-09-28	2015-04-10	Интарсия Терапьютикс, Инк.	Быстрое достижение и/или прекращение существенной стабильной доставки лекарственного средства
BR112013012726B1 (pt) *	2010-11-25	2022-03-29	Shan Dong Luye Pharmaceutical Co., Ltd	Composições de rotigotina, derivados da mesma, ou sais farmaceuticamente aceitáveis de rotigotina ou seus derivados
US20120208755A1 (en)	2011-02-16	2012-08-16	Intarcia Therapeutics, Inc.	Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
JO3410B1 (ar)	2011-06-07	2019-10-20	Otsuka Pharma Co Ltd	تركيبة أريبيبرازول مجفف بالتبريد
US9889085B1 (en)	2014-09-30	2018-02-13	Intarcia Therapeutics, Inc.	Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
WO2016196851A2 (en)	2015-06-03	2016-12-08	Intarcia Therapeutics, Inc.	Implant placement and removal systems
IL262802B2 (en)	2016-05-16	2025-04-01	Intarcia Therapeutics Inc	Glucagon receptor selective polypeptides and methods of using them
USD840030S1 (en)	2016-06-02	2019-02-05	Intarcia Therapeutics, Inc.	Implant placement guide
USD860451S1 (en)	2016-06-02	2019-09-17	Intarcia Therapeutics, Inc.	Implant removal tool
CN110225762A (zh)	2017-01-03	2019-09-10	因塔西亚制药公司	包括glp-1受体激动剂的连续施用和药物的共同施用的方法
WO2018172850A1 (en)	2017-03-20	2018-09-27	Teva Pharmaceuticals International Gmbh	Sustained release olanzapine formulaitons
KR102045721B1 (ko) *	2019-03-27	2019-11-18	주식회사 씨트리	아픽사반 함유 미립구 제조용 분산상의 조성물 및 이로부터 제조되는 생체적합성 고분자 기반 아픽사반 함유 미립구

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4384975A (en) *	1980-06-13	1983-05-24	Sandoz, Inc.	Process for preparation of microspheres
US4389330A (en) *	1980-10-06	1983-06-21	Stolle Research And Development Corporation	Microencapsulation process
GB9009229D0 (en) *	1990-04-25	1990-06-20	Lilly Industries Ltd	Pharmaceutical compounds
WO1994010982A1 (en) *	1992-11-17	1994-05-26	Yoshitomi Pharmaceutical Industries, Ltd.	Sustained-release microsphere containing antipsychotic and process for producing the same
EP0733368A1 (en) *	1995-03-24	1996-09-25	Eli Lilly And Company	Granule fomulation for olanzapine

1997
- 1997-09-09 GB GBGB9718986.4A patent/GB9718986D0/en not_active Ceased
1998
- 1998-08-26 ZA ZA9807762A patent/ZA987762B/xx unknown
- 1998-09-07 EP EP98941610A patent/EP1011680A2/en not_active Withdrawn
- 1998-09-07 WO PCT/GB1998/002692 patent/WO1999012549A2/en not_active Application Discontinuation
- 1998-09-07 NZ NZ502710A patent/NZ502710A/en unknown
- 1998-09-07 CA CA002302762A patent/CA2302762A1/en not_active Abandoned
- 1998-09-07 AU AU89925/98A patent/AU745511B2/en not_active Ceased
- 1998-09-07 JP JP2000510446A patent/JP2001515862A/ja active Pending
- 1998-09-09 AR ARP980104487A patent/AR017079A1/es unknown
2000
- 2000-03-09 NO NO20001219A patent/NO20001219D0/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
WO1999012549A3 (en)	1999-05-06
NO20001219L (no)	2000-03-09
CA2302762A1 (en)	1999-03-18
AU745511B2 (en)	2002-03-21
NZ502710A (en)	2001-09-28
EP1011680A2 (en)	2000-06-28
ZA987762B (en)	2000-02-28
GB9718986D0 (en)	1997-11-12
AU8992598A (en)	1999-03-29
AR017079A1 (es)	2001-08-22
JP2001515862A (ja)	2001-09-25
WO1999012549A2 (en)	1999-03-18

Publication	Publication Date	Title
NO20001219D0 (no)	2000-03-09	Blanding for medikament-administrasjon
NO994003L (no)	1999-10-19	Farmasoytisk blanding
NO975931D0 (no)	1997-12-17	Blanding for administrering av medikament
NO992427D0 (no)	1999-05-20	Farmas°ytisk blanding
ID23874A (id)	2000-05-25	Obat
ID24654A (id)	2000-07-27	Formulasi farmasi omeprazola
FI972292A0 (fi)	1997-05-30	Administrering av diabetes
DK0797991T3 (da)	2004-04-05	Lægemiddelformulering med forhalet frigivelse
DK1035833T3 (da)	2006-01-09	Sammensætning til nasal indgivelse
EE9700241A (et)	1998-04-15	Farmatseutiline kompositsioon transdermaalseks manustamiseks
DE69821457D1 (de)	2004-03-11	Zusammensetzungen mit kontrollierter Wirkstoffabgabe
DK0998272T3 (da)	2003-08-25	Farmaceutisk præparat til kombinationen piperidinoalkanoldekongestivum
PL328399A1 (en)	1999-01-18	Drug administration aid
DE69935681D1 (de)	2007-05-10	Vorrichtungen zur Medikamentverabreichung
FI971279A0 (fi)	1997-03-26	Lääkkeitä
KR950700754A (ko)	1995-02-20	신규의 약물(novel medicament)
DE69810189D1 (de)	2003-01-30	Zusammensetzungen mit kontrollierter Wirkstoffabgabe
BR9610396A (pt)	1999-07-06	Formulação farmacêutica
FR2767121B1 (fr)	1999-10-29	Distributeur de medicaments
NO995251D0 (no)	1999-10-27	FremgangsmÕte for administrering av haloterapi
DK0868911T3 (da)	2003-01-20	Rapamycinpræparater til oral indgivelse
NO995039L (no)	1999-12-17	Gastrisk bibeholdt farmasoeytisk preparat
NO994619L (no)	1999-11-23	Farmasöytiske blandinger
NO992999D0 (no)	1999-06-18	Farmas°ytisk blanding for oral administrering
NO20003141D0 (no)	2000-06-16	Farmasøytiske blandinger

Legal Events

Date	Code	Title	Description
2003-06-02	FC2A	Withdrawal, rejection or dismissal of laid open patent application